Live Breaking News & Updates on Prnewswire Sirnaomics Inc

Stay updated with breaking news from Prnewswire sirnaomics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sirnaomics Strengthens Its Development and Manufacturing Leadership with Promotions of Two Biopharma Veterans, Dr. Steven Long and Dr. Edward Wang

/PRNewswire/ Sirnaomics, Inc., a biopharmaceutical company engaged in discovery and development of RNAi therapeutics against cancer and fibrotic diseases,. ....

United Kingdom , United States , Eteläuomen Läi , Mark Corbae , Edwardy Wang , Stephanie Carrington , George Ji , Steven Long , Patrick Lu , Prnewswire Sirnaomics Inc , University Of Science , Boehringer Ingelheim , Melinda Gates Foundation , Newlink Genetics Inc , Sirnaomics Inc , Novartis Genetic Therapy Center , Helsinki University Of Technology , Roche Pharmaceuticals Corporation , Us National Cancer Institute , Drug Administration , Tokyo Institute Of Technology , Quality Biotech Inc , Fudan University , Parexel International At Ben Venue Laboratory , University Of Pennsylvania , University Of Leeds ,

Sirnaomics Strengthens Its Development and Manufacturing Leadership with Promotions of Two Biopharma Veterans, Dr. Steven Long and Dr. Edward Wang

/PRNewswire/ Sirnaomics, Inc., a biopharmaceutical company engaged in discovery and development of RNAi therapeutics against cancer and fibrotic diseases,. ....

United Kingdom , United States , Eteläuomen Läi , Mark Corbae , Edwardy Wang , Stephanie Carrington , George Ji , Steven Long , Patrick Lu , Prnewswire Sirnaomics Inc , University Of Science , Boehringer Ingelheim , Melinda Gates Foundation , Newlink Genetics Inc , Sirnaomics Inc , Novartis Genetic Therapy Center , Helsinki University Of Technology , Roche Pharmaceuticals Corporation , Us National Cancer Institute , Drug Administration , Tokyo Institute Of Technology , Quality Biotech Inc , Fudan University , Parexel International At Ben Venue Laboratory , University Of Pennsylvania , University Of Leeds ,

Sirnaomics Receives FDA Approval of IND for Phase 1 Clinical Trial of Systemic RNAi Therapeutic STP707 for Solid Tumor Treatment

Sirnaomics Receives FDA Approval of IND for Phase 1 Clinical Trial of Systemic RNAi Therapeutic STP707 for Solid Tumor Treatment
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Mark Corbae , Stephanie Carrington , Michael Molyneaux , Patrick Lu , Prnewswire Sirnaomics Inc , Lysine Co , Drug Administration , Sirnaomics Inc , Dose Escalation Study , Dose Expansion Study , Antitumor Activity , Chief Medical Officer , Histidine Lysine Co Polymer , Global Vision , Patient Centered , Medical Officer , ஒன்றுபட்டது மாநிலங்களில் , மாற்றாந்தாய் கேரிங்டன் , மைக்கேல் மோலிநி , பேட்ரிக் லு , டோஸ் விரிவாக்கம் படிப்பு , தலைமை மருத்துவ அதிகாரி , உலகளாவிய பார்வை , நோயாளி மையமாக , மருத்துவ அதிகாரி ,

Sirnaomics Reports Positive Data from Phase 2a Study of STP705 for Treatment of Squamous Cell Skin Cancer

Press release content from PR Newswire. The AP news staff was not involved in its creation.
Sirnaomics Reports Positive Data from Phase 2a Study of STP705 for Treatment of Squamous Cell Skin Cancer
December 20, 2020 GMT
Sirnaomics Company Logo (PRNewsfoto/Sirnaomics, Inc.)
GAITHERSBURG, Md. and SUZHOU BIOBAY, China, Dec. 20, 2020 /PRNewswire/ Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced positive efficacy and safety results from a Phase 2a clinical study of the company’s lead drug candidate, STP705, for treatment of squamous cell skin cancer.
The open label, dose escalation study was designed to evaluate the efficacy and safety of intralesional injection of STP705 in adult patients with cutaneous squamous cell carcinoma in situ (isSCC, Bowen’s disease), confirmed with biopsy samples. The objective was to determine the safe and effective rec ....

United States , Marks Nestor , Brian Berman , Mark Corbae , Stephanie Carrington , Michael Molyneaux , Patrick Lu , Prnewswire Sirnaomics Inc , International Agency For Research On Cancer , A World Health Organization , Sirnaomics Inc , Sirnaomics Chief Medical , Cosmetic Research , Non Melanoma Skin Cancer , Squamous Cell Carcinoma In Situ , World Health Organization , Orphan Drug Designation , Global Vision , Patient Centered , ஒன்றுபட்டது மாநிலங்களில் , மதிப்பெண்கள் கூடு , பிரையன் பெர்மன் , மாற்றாந்தாய் கேரிங்டன் , மைக்கேல் மோலிநி , பேட்ரிக் லு , ஒப்பனை ஆராய்ச்சி ,